Norges Bank’s Roivant Sciences ROIV Stock Holding History

Norges Bank’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$168M	Buy	+4,747,472	New	+$140M	0.02%	592
2026 Q1	–	Sell	-5,195,859	Closed	-$113M	–	1114
2025 Q4	$113M	Buy	+5,195,859	New	+$103M	0.01%	714
2025 Q3	–	Sell	-616,869	Closed	-$6.95M	–	1237
2025 Q2	$6.95M	Sell	616,869 -3,964,951	-87%	-$43M	﹤0.01%	1299
2025 Q1	$46.2M	Buy	4,581,820 +148,806	+3%	+$1.61M	0.01%	974
2024 Q4	$52.4M	Buy	4,433,014 +47,074	+1%	+$557K	0.01%	948
2024 Q3	$50.6M	Buy	4,385,940 +145,163	+3%	+$1.65M	0.01%	968
2024 Q2	$44.8M	Sell	4,240,777 -25,915	-0.6%	-$284K	0.01%	950
2024 Q1	$45M	Buy	4,266,692 +570,725	+15%	+$6.15M	0.01%	985
2023 Q4	$41.5M	Buy	3,695,967 +1,175,910	+47%	+$11.5M	0.01%	994
2023 Q3	$29.4M	Buy	2,520,057 +2,411,125	+2,213%	+$27.3M	0.01%	1068
2023 Q2	$1.1M	Buy	+108,932	New	+$974K	﹤0.01%	1924

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Norges Bank's ROIV Position: Q2 2026 in Review

Norges Bank opened a new position in Roivant Sciences (ROIV) in Q2 2026: 4,747,472 shares worth $168M. The stake represents 0.02% of the portfolio and ranks #592 among its holdings. This is a return to the name: Norges Bank previously reported a position in ROIV as recently as Q4 2025.

Norges Bank first reported a position in ROIV in Q2 2023 and has held it in 11 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Norges Bank held 4,747,472 shares of Roivant Sciences worth $168M as of Q2 2026.
Roivant Sciences was a new Norges Bank position in Q2 2026.
Roivant Sciences made up 0.02% of Norges Bank's portfolio in Q2 2026, its #592 holding.
Norges Bank first reported a position in Roivant Sciences in Q2 2023 and has held it in 11 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.